- Dividend Data
- Posts
- UNH Stock Crashes 50% + Dividend Raises This Week
UNH Stock Crashes 50% + Dividend Raises This Week
Hey, Zach Here!
A top dividend growth stock is selling off…
Today’s topics:
A Great Buying Opportunity for UNH stock?
New Dividend Raises
My $390.90 dividend week
The Key Story
UnitedHealth Stock Crashes 50% - Buy The Dip on UNH?

UNH stock price
One the best dividend growth stocks of all time, UNH, just rocketed to the top of my watchlist. 🚀
It’s now down -45.54% from the 200 day price average.
Is this a buying opportunity? Well, first let’s evaluate why the stock sold off.
Reasons for Sell-off
Guidance Cut: UnitedHealth slashed its 2025 profit forecast, lowering adjusted earnings guidance to $26-$26.50 per share from $29.50-$30 per share. This major revision was due to higher-than-expected healthcare usage by older Americans enrolled in Medicare Advantage plans and lower government reimbursements [source].
Regulatory Scrutiny: The company faced a reported criminal investigation by the U.S. Department of Justice into possible Medicare fraud, although UnitedHealth stated it had not been informed of such a probe [source].
Management Changes: CEO Andrew Witty stepped down, and the company withdrew its 2025 guidance, which led to a significant drop in stock price. This was compounded by a securities class action lawsuit alleging misleading statements by the company [source].
Opportunities
Markedly cheaper valuation after the sell-off – the stock now trades around ~9× forward earnings, well below its long-term average, so a “re-rating” back to historical multiples could deliver a 25--30 % rebound if fundamentals prove intact.
Scale advantages & diversified platform – as the largest U.S. managed-care company, UNH pairs its insurance arm with Optum’s pharmacy-benefit, data-analytics and care-delivery businesses, giving it cost leverage and multiple profit sources.
Structural tailwinds from rising healthcare costs – even with flat membership growth, medical-cost inflation flows through to revenue, sustaining mid-single-digit top-line growth over time.
Resilient cash generation – steady free cash flow supports dividends, buybacks and bolt-on acquisitions, cushioning periods of volatility.
History of weathering regulatory scares – political heat on managed care recurs every few years; so far UNH has continued to post solid earnings once headline risk fades.
Risks
DOJ/Medicaid fraud investigation – potential fines, clawbacks or operating restrictions could hit earnings and damage reputation.
Leadership & guidance uncertainty – the abrupt CEO resignation and withdrawal of guidance raise questions about internal controls and near-term visibility.
Regulatory & political pressure – bipartisan scrutiny of insurer margins, possible reimbursement cuts or pricing caps could compress the medical-loss-ratio and profitability.
Limited organic growth runway – with U.S. insurance penetration already high, volume growth is scarce; earnings rely heavily on managing cost trends, where mis-estimates can cause sharp downside.
“Unknown unknowns” in earnings quality – if investigations uncover systemic issues (similar to past healthcare fraud cases), profits could be restated and the share price fall another 30--50 %.
Sentiment & momentum reversal – Wall Street typically shuns uncertainty; until the investigation and earnings outlook are clarified, the multiple may stay depressed.
Conclusion
The combination of disappointing earnings guidance, regulatory challenges, and management upheaval has led to a significant sell-off in UnitedHealth's stock in 2025. Despite these challenges, the company is taking steps to address the issues and remains optimistic about its long-term growth prospects.
If UNH weathers this storm, then this could represent a historic buying opportunity for the stock. The dividend yield is now at the highest level ever at 2.88%.

UNH dividend yield, source: DividendData.com
This is a company with a history of reliable dividend raises. In fact, the 10 year dividend CAGR is +18.80%. The most recent increase was +11.70%.

UNH dividend history & growth, source: DividendData.com
🚀 New Dividend Raises:
Dividend stocks continue to grow dividend payments. That includes top stocks owned by Warren Buffett like Chubb.
P.S. Dividend News is brought to you by our partner Seeking Alpha.
Try Premium free for 7 days + $30 off
💰My Dividends This Week
I just earned $390.90 in dividends last week. That was from my 3 oil & gas midstream stocks, including new additions like $MPLX and $HESM.
I’ll be doing stock analysis videos both those soon…
Got paid $199 in dividends today!
- $124.22 from $HESM Hess Midstream LP
- $74.78 from $EPD Enterprise Products Partners L.P.— Dividend Data (@dividend_data)
3:51 PM • May 14, 2025
Got a $191.30 dividend from $MPLX today
Reinvested
— Dividend Data (@dividend_data)
4:17 PM • May 16, 2025
How did you like today’s newsletter? |
📅 Keep Investing. Stay informed.
– Zach
Founder, Dividend Data
P.S. Questions or suggestions? Reply to this email—I'd love your feedback!
Follow on YouTube | Listen on Spotify | Visit DividendData.com
Disclaimer: Dividend Dividend (Dividend Data LLC) is not a professional financial service. All materials released from Dividend Data (Dividend Data LLC) are for educational and entertainment purposes. Dividend Data (Dividend Data LLC) is not a replacement for a professional's opinion. Contributors to the Dividend Data (Dividend Data LLC) might have equities mentioned in the newsletter